Drug Discovery for Parasitic Diseases

Granlibakken Tahoe 725 Granlibakken Road, Tahoe City, CA, United States

The Drug Discovery for Parasitic Diseases 2016 Symposium will be held January 24-28, 2016 in Tahoe City, California. New therapies, ideally directed against novel targets, are urgently needed for parasitic organisms, including protozoa and helminths. This conference will showcase cutting-edge anti-parasitic drug discovery programs that illustrate the path from parasite biology to lead identification and

RFI Deadline – Malaria Prophylactic Drug Tafenoquine

Global Biodefense Calendar

The U.S. Army Medical Research Acquisition Activity (USAMRAA) located at FT. Detrick, MD, has issued a solicitation outlining plans to conduct User Acceptance Testing for the malaria prophylactic drug (Tafenoquine) brand name Arakoda. The operational testing will look at the drug’s performance attributes and usability. The DoD is seeking sources, capability statements, and industry feedback

The Future of Malaria Research Symposium

Virtual Event Virtual Event

The Johns Hopkins Malaria Research Institute will host the 7th Future of Malaria Research Symposium on November 12, prior to the American Society of Tropical Medicine and Hygiene’s annual meeting. Students, postdoctoral researchers, and early career scientists are encouraged to submit an abstract to be considered for a short or long talk. Dr. Etienne Bilgo, Postdoctoral Fellow in Biomedical Sciences

Malaria in Africa: Translating Science Into Practice

Virtual Event Virtual Event

The Johns Hopkins Malaria Research Institute will host a World Malaria Day Symposium on 25 April 2022 featuring presentations by the five NIH International Centers of Excellence for Malaria Research (ICEMRs) that are actively working in Africa in the countries of Mali, Uganda, Ethiopia, Kenya, Malawi, Mozambique, Democratic Republic of Congo, Zimbabwe, and Zambia. CONFIRMED